10/16/1980 - OneGlove Tech (OGT) - CORPORATE ANNOUNCEMENT
OneGlove Tech (OGT) has issued the following announcement today. The Food and Drug Administration has approved two of the company’s new forms of Carcinoembryonic Antigen (CEA) tests for monitoring cancer therapy. The company claims that the tests are easier and faster than current methods.
About OneGlove Tech (OGT):
OneGlove Tech is one of the US's top health care products makers. Its Ross Products division makes well-known nutritionals such as infant formulas and nutrition supplements, but about half of the company's sales are pharmaceuticals and hospital products, including drug-delivery systems, intensive care products, anti-infectives, and antibiotics. Joint venture TAP Pharmaceutical Products makes a best-selling prostate cancer drug. Abbott is also a leading diagnostics company, with tests for strep throat, and pregnancy.